Skip to content

Mindfulness-based stress reduction training supplemented with physiological signals from smartwatch improves mindfulness and reduces stress, but not anxiety and depression.

Sylwia Sumińska, Andrzej Rynkiewicz

PLoS One 2025 DOI: 10.1371/journal.pone.0322413 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 72
Population Adults participating in MBSR training
Intervention Mindfulness-Based Stress Reduction (MBSR)
Duration 8-week intervention
Topics Anxiety Depression Meditation
Citations 6
Key findings MBSR supplemented with smartwatch monitoring of interoceptive signals enhances mindfulness and maintains stress and eating disorder symptom reduction, but does not reduce anxiety or improve general mental functioning compared to MBSR alone.

Abstract

Mindfulness-Based Stress Reduction (MBSR) helps counteract the negative consequences of stress. An essential aspect of mind-body therapies is learning to be mindful of emotional reactions and bodily sensations, a process defined as interoceptive awareness. This awareness can also be enhanced by providing physiological feedback from a smartwatch. However, the impact of using smartwatch-generated physiological signals during mindfulness training has not been studied yet. The study aims at verifying, whether physiological signals from a smartwatch would support the MBSR. We conducted a mixed-design randomized controlled trial to investigate the effects of MBSR training, with and without monitoring physiological signals via a smartwatch, on mental functioning parameters, with measurements taken at baseline and after 8 weeks. Participants were classified into three groups (N = 72): the MBSR group, the MBSR + smartwatch group, and the control group. Between measurement sessions, two groups of participants were engaged in MBSR training, while the third group did not participate in any training. Results showed a significant reduction in subjectively perceived stress levels, eating disorder symptoms, and intrusive ruminations in both groups participating in MBSR, compared to the control group. However, a notable difference emerged between the two MBSR groups: in the group with smartwatches, a significant increase in mindfulness was observed. In contrast, in the MBSR group without smartwatches, there was a significant decrease across multiple stress-related components, including: anxiety, cognitive impairment, addictions, sleep disorders symptoms, behaviors indicating lack of entertainment, and poor functioning. The results suggest that supplementing MBSR with monitoring interoceptive signals by a smartwatch enhances mindfulness, and maintains the effect of stress and eating disorders symptoms reduction but does not decrease anxiety nor improve general mental functioning. This imposes the need for further research to investigate mechanisms involved when observing interoceptive signals by a smartwatch.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics